[ORGANIZATION]
Lexicon Pharmaceuticals
Featured in 2 tracked stories · first seen
Also covered in
-
Vogenx raises $81.3 million in Nasdaq IPO for metabolic disease research
[BUSINESS] · 3 sources ·
[ORGANIZATION]
Featured in 2 tracked stories · first seen
[BUSINESS] · 3 sources ·